Zen-Zen is the Head of Engineering at Bayer AG Supply Center Grenzach in Germany. She holds a master's degree in Biotechnology from TU Braunschweig, Germany...
As my first year on the ISPE Board of Directors draws to a close, I find myself reflecting on a year filled with unprecedented learning, growth, and valuable insights.
Serving as a representative for Emerging Leaders and students on the International Board has been a transformative journey that has broadened my perspectives and has also significantly contributed to my personal and professional development. The experience of working with thought leaders in the industry with diverse backgrounds has allowed me to strengthen my knowledge and interpersonal skills.
Stepping into the role of a board member for ISPE was a decision driven by a desire to contribute to a greater purpose. Little did I know that this experience would extend far beyond my initial expectations. One of the most remarkable aspects of this journey has been the exposure to the operations of a large global nonprofit in the pharmaceutical industry. Witnessing the orchestration of events, initiatives, and collaborations on an international scale has been eye-opening. It underscored the critical importance of compelling visions, effective leadership, clear communication, and strategic planning in driving the mission of an organization that spans continents.
During my tenure, I had the privilege of engaging with professionals from diverse backgrounds and cultures. This global perspective not only enriched my understanding of the challenges and opportunities facing the pharmaceutical industry, but also highlighted the universal nature of our shared goals. From regulatory harmonization to technological innovation, it became evident that the exchange of ideas across borders accelerates progress and fosters a sense of camaraderie among professionals worldwide.
The lessons gleaned from my year on the ISPE Board of Directors have permeated every facet of my career. One of the most impactful realizations has been the power of collaboration. Working alongside accomplished individuals with varied expertise emphasized the significance of interdisciplinary cooperation. Just as the board brings together professionals from diverse fields, so does the pharmaceutical industry require the seamless integration of scientific, regulatory, and business perspectives.
Additionally, the experience showed me the importance of adaptability in an ever-evolving landscape. Navigating the complexities of a global non-profit organization in an era of rapid change highlighted the need for agility and innovative thinking. The pharmaceutical industry, like ISPE, is beginning to operate more and more in a dynamic environment shaped by technological advancements, regulatory shifts, and societal demands. Embracing change rather than resisting it is a fundamental lesson that I will carry forward.
Furthermore, my interactions with fellow board members and industry leaders illuminated the essence of mentorship and continuous learning. Each conversation served as a wellspring of knowledge, offering insights that extended beyond my existing expertise. The willingness to learn from others, regardless of their position or background, has proven invaluable. It reinforces the notion that growth is a perpetual journey, and humility is the compass that guides us toward new horizons.
As I bid farewell to my role on the ISPE Board of Directors, I do so with profound gratitude for the opportunities and lessons this experience has bestowed upon me. The past year has demonstrated that service to a global nonprofit organization transcends mere involvement—it is a commitment to contributing to a larger collective purpose. My journey with ISPE has been shaped by numerous volunteering opportunities made available to me, all thanks to the trust within the organization and the enthusiasm and engagement of the emerging leaders and students around me.
As I move forward, I firmly hold the belief that the valuable knowledge acquired over this transformative year will influence my personal and professional pursuits in the future. The lasting impression of ISPE’s impact on me serves as a powerful reminder of what can be achieved through collaboration and united efforts toward a shared objective.
ISPE GAMP® 5: A Risk-Based Approach to Compliant GxP Computerized Systems (Second Edition) outlines how to apply a risk-based approach to GxP computerized systems and is aligned with the FDA draft guidance “Computer...
An ISPE campaign in 2016 piqued my interest in the Women in Pharma committee because I’m an advocate for women in the workplace. When I became President of the ISPE Philippines Affiliate in 2017, I knew that Women in Pharma...
Next year promises to be a busy one for ISPE. The year starts with the 2024 ISPE Facilities of the Future Conference in San Francisco and is quickly followed by the